India Large Volume Parenteral Market Size, Share & Trends Analysis Report By Application (Therapeutic Injections, Fluid Balance Injections, Nutritious Injections), By Volume, By End Use, And Segment Forecasts, 2021 - 2028
This report can be delivered to the clients within 72 Business Hours
India Large Volume Parenteral Market Growth & Trends
The India large volume parenteral market size is expected to reach USD 134.0 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.0% from 2021 to 2028. Large Volume Parenteral (LVP) injections are used for either total or partial nutrition when oral intake is insufficient or challenging. Earlier, these formulations were used for patients undergoing surgical procedures or those admitted to a hospital.
Currently, they are used as substitutes for nutrition obtained from a healthy diet. However, the demand for LVPs has significantly increased due to the growing adoption of parenteral nutrition over enteral nutrition among COVID-19 patients for improving drug absorption, shorter hospital stays, and reduced risk of infections. This is anticipated to drive the market over the forecast period.
In 2020, the nutritious injections application segment accounted for the largest revenue share. This is attributed to the growing adoption of these products in delivering intravenous carbohydrates, amino acids, electrolytes, and minerals to meet adequate nutritional requirements when enteral nutrition mode is insufficient, not possible, or contraindicated. On the other hand, the therapeutic injections segment is anticipated to register the fastest growth during the forecast period. The increasing prevalence of chronic conditions, such as cancer, can significantly impact the adoption of LVPs in the country, as they can provide vital nutrients to help maintain strength, energy, and hydration in patients from diagnosis to recovery.
In 2020, the 500 ml volume segment accounted for the largest revenue share. The increasing number of ICU admissions, rising demand for parenteral formulation among critically ill patients, growing preference for single-dose administration of vaccines and drugs, and increasing prevalence of various chronic disorders such as cancer and diabetes are some of the factors expected to propel this segment. On the other hand, the 100 ml volume segment is anticipated to register the fastest growth during the forecast period, as it can help avoid adverse effects related to nutrition and electrolyte imbalances.
In 2020, the hospital and other healthcare facilities segment dominated the market. The segment is anticipated to maintain its dominance during the forecast period. The growing prevalence of chronic conditions requiring dietary management in patients and increasing incidence of hospital-acquired malnutrition are expected to boost demand for LVPs. In addition, these formulations are administered preoperatively to reduce the rate of complications and hospital stay among surgical ICU patients. This is likely to increase the demand for LVPs among surgical and intensive care patients, thereby, propelling segment growth.
India Large Volume Parenteral Market Report Highlights
India Large Volume Parenteral Market Growth & Trends
The India large volume parenteral market size is expected to reach USD 134.0 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.0% from 2021 to 2028. Large Volume Parenteral (LVP) injections are used for either total or partial nutrition when oral intake is insufficient or challenging. Earlier, these formulations were used for patients undergoing surgical procedures or those admitted to a hospital.
Currently, they are used as substitutes for nutrition obtained from a healthy diet. However, the demand for LVPs has significantly increased due to the growing adoption of parenteral nutrition over enteral nutrition among COVID-19 patients for improving drug absorption, shorter hospital stays, and reduced risk of infections. This is anticipated to drive the market over the forecast period.
In 2020, the nutritious injections application segment accounted for the largest revenue share. This is attributed to the growing adoption of these products in delivering intravenous carbohydrates, amino acids, electrolytes, and minerals to meet adequate nutritional requirements when enteral nutrition mode is insufficient, not possible, or contraindicated. On the other hand, the therapeutic injections segment is anticipated to register the fastest growth during the forecast period. The increasing prevalence of chronic conditions, such as cancer, can significantly impact the adoption of LVPs in the country, as they can provide vital nutrients to help maintain strength, energy, and hydration in patients from diagnosis to recovery.
In 2020, the 500 ml volume segment accounted for the largest revenue share. The increasing number of ICU admissions, rising demand for parenteral formulation among critically ill patients, growing preference for single-dose administration of vaccines and drugs, and increasing prevalence of various chronic disorders such as cancer and diabetes are some of the factors expected to propel this segment. On the other hand, the 100 ml volume segment is anticipated to register the fastest growth during the forecast period, as it can help avoid adverse effects related to nutrition and electrolyte imbalances.
In 2020, the hospital and other healthcare facilities segment dominated the market. The segment is anticipated to maintain its dominance during the forecast period. The growing prevalence of chronic conditions requiring dietary management in patients and increasing incidence of hospital-acquired malnutrition are expected to boost demand for LVPs. In addition, these formulations are administered preoperatively to reduce the rate of complications and hospital stay among surgical ICU patients. This is likely to increase the demand for LVPs among surgical and intensive care patients, thereby, propelling segment growth.
India Large Volume Parenteral Market Report Highlights
- The market is expected to grow well over the forecast period owing to high adoption rates of LVPs owing to growing physician preference for single-dose administration among critically ill patients
- The nutritious injections application segment dominated the market in 2020, owing to the increasing adoption of these formulations to fulfill adequate nutritional requirements
- The 500 ml volume segment dominated the market in 2020 owing to the increasing prevalence of chronic diseases such as cancer and CVDs
- The hospital and other healthcare facilities end-use segment dominated the market in 2020 owing to an increase in the number of surgical procedures and rising prevalence of hospital-acquired malnutrition among patients
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Research Methodology
1.1.1 Information Procurement
1.1.1.1 Purchased Database:
1.1.1.2 Gvr’s Internal Database
1.1.2 Primary Research:
1.2 Research Scope and Assumptions
1.3 List of Secondary Sources
1.4 List of Primary Sources
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
2.4 India Large Volume Parenteral Market Snapshot
CHAPTER 3 INDIA LARGE VOLUME PARENTERAL MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Segmentation and Scope
3.1.1 Market driver analysis
3.1.1.1 Rising number of surgeries
3.1.1.2 Faster method for administering drugs
3.1.1.3 Growing preference for single-dose administration of vaccines and drugs to treat chronic diseases
3.1.1.4 Increase in local LVP manufacturing
3.1.2 Market restraint analysis
3.1.2.1 Challenges in the formulation of LVPs
3.2 Penetration and Growth Prospect Mapping
3.3 India Large Volume Parenteral Market Analysis Tools
3.3.1 Industry Analysis - Porter’s
3.3.1.1 Bargaining Power Of Suppliers - High
3.3.1.2 Bargaining Power Of The Buyers - Low
3.3.1.3 Threat Of Substitution - Low
3.3.1.4 Threats Of New Entrants - Moderate
3.3.1.5 Competitive Rivalry - Moderate
3.3.2 Pestel Analysis
3.3.2.1 Political And Legal Landscape
3.3.2.2 Economic and Social Landscape
3.3.2.3 Environment and Technology Landscape
3.4 India LVP Market: Regulatory Scenario
3.4.1 Drug Regulation And Control
3.4.2 Procedure For Drug Application In India
3.4.2.1 List Of Documents Required To Be Submitted
3.4.3 Import And Manufacturing Licenses And Approvals
3.4.4 Labelling Requirements
3.4.5 Drug Price Regulation
3.4.6 Trends In Drug Price Control - India
3.4.7 Regulations On Patent Protection
CHAPTER 4 GLOBAL INDIA LARGE VOLUME PARENTERAL MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
4.1 Segment Dashboard
4.2 Market: Application Analysis, 2020 & 2028 (USD Million)
4.2.1 Therapeutic Injections
4.2.1.1 Market Estimates And Forecasts, 2014 - 2028 (USD Million)
4.2.2 Fluid Balance Injections
4.2.2.1 Market Estimates And Forecasts, 2014 - 2028 (USD Million)
4.2.3 Nutritious Injections
4.2.3.1 Market Estimates And Forecasts, 2014 - 2028 (USD Million)
CHAPTER 5 INDIA LARGE VOLUME PARENTERAL MARKET: VOLUME ESTIMATES & TREND ANALYSIS
5.1 Segment Dashboard
5.2 Market: Application Analysis, 2020 & 2028 (USD Million)
5.2.1 100 ML
5.2.1.1 Market estimates and forecasts, 2014 - 2028 (USD Million)
5.2.2 250 ML
5.2.2.1 Market estimates and forecasts, 2014 - 2028 (USD Million)
5.2.3 500 ML
5.2.3.1 Market estimates and forecasts, 2014 - 2028 (USD Million)
5.2.4 1000 ML
5.2.4.1 Market estimates and forecasts, 2014 - 2028 (USD Million)
5.2.5 2000 ML
5.2.5.1 Market estimates and forecasts, 2014 - 2028 (USD Million)
CHAPTER 6 INDIA LARGE VOLUME PARENTERAL MARKET: END-USE ESTIMATES & TREND ANALYSIS
6.1 Segment Dashboard
6.2 Market: End-use Analysis, 2020 & 2028 (USD Million)
6.2.1 Hospitals & other healthcare facilities
6.2.1.1 Market estimates and forecasts, 2014 - 2028 (USD Million)
6.2.2 Home care
6.2.2.1 Market estimates and forecasts, 2014 - 2028 (USD Million)
CHAPTER 7 COMPETITIVE LANDSCAPE
7.1 Strategy Framework
7.2 LVP Manufacturers in India
7.3 India LVP Market: Market Position Analysis (Based on Application, Product Benchmarking, Regional Presence, and Recent Updates)
7.3.1 Marketing Of Lvp To Healthcare Providers And Distribution Channels
7.4 Company Profiles
7.4.1 B. BRAUN MELSUNGEN AG
7.4.1.1 Company overview
7.4.1.2 Financial performance
7.4.1.3 Product benchmarking
7.4.1.4 Strategic initiatives
7.4.2 FRESENIUS KABI AG
7.4.2.1 Company overview
7.4.2.2 Financial performance
7.4.2.3 Product benchmarking
7.4.2.4 Strategic initiatives
7.4.3 BAXTER
7.4.3.1 Company overview
7.4.3.2 Financial performance
7.4.3.3 Product benchmarking
7.4.3.4 Strategic initiatives
7.4.4 OTSUKA PHARMACEUTICALS CO. LTD
7.4.4.1 Company overview
7.4.4.2 Financial performance
7.4.4.3 Product benchmarking
7.4.4.4 Strategic initiatives
7.4.5 SICHUAN KELUN
7.4.5.1 Company overview
7.4.5.2 Financial performance
7.4.5.3 Product benchmarking
7.4.6 ALBERT DAVID LTD.
7.4.6.1 Company overview
7.4.6.2 Financial performance
7.4.6.3 Product benchmarking
7.4.7 BML PARENTERAL DRUGS
7.4.7.1 Company overview
7.4.7.2 Financial performance
7.4.7.3 Product benchmarking
1.1 Research Methodology
1.1.1 Information Procurement
1.1.1.1 Purchased Database:
1.1.1.2 Gvr’s Internal Database
1.1.2 Primary Research:
1.2 Research Scope and Assumptions
1.3 List of Secondary Sources
1.4 List of Primary Sources
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
2.4 India Large Volume Parenteral Market Snapshot
CHAPTER 3 INDIA LARGE VOLUME PARENTERAL MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Segmentation and Scope
3.1.1 Market driver analysis
3.1.1.1 Rising number of surgeries
3.1.1.2 Faster method for administering drugs
3.1.1.3 Growing preference for single-dose administration of vaccines and drugs to treat chronic diseases
3.1.1.4 Increase in local LVP manufacturing
3.1.2 Market restraint analysis
3.1.2.1 Challenges in the formulation of LVPs
3.2 Penetration and Growth Prospect Mapping
3.3 India Large Volume Parenteral Market Analysis Tools
3.3.1 Industry Analysis - Porter’s
3.3.1.1 Bargaining Power Of Suppliers - High
3.3.1.2 Bargaining Power Of The Buyers - Low
3.3.1.3 Threat Of Substitution - Low
3.3.1.4 Threats Of New Entrants - Moderate
3.3.1.5 Competitive Rivalry - Moderate
3.3.2 Pestel Analysis
3.3.2.1 Political And Legal Landscape
3.3.2.2 Economic and Social Landscape
3.3.2.3 Environment and Technology Landscape
3.4 India LVP Market: Regulatory Scenario
3.4.1 Drug Regulation And Control
3.4.2 Procedure For Drug Application In India
3.4.2.1 List Of Documents Required To Be Submitted
3.4.3 Import And Manufacturing Licenses And Approvals
3.4.4 Labelling Requirements
3.4.5 Drug Price Regulation
3.4.6 Trends In Drug Price Control - India
3.4.7 Regulations On Patent Protection
CHAPTER 4 GLOBAL INDIA LARGE VOLUME PARENTERAL MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
4.1 Segment Dashboard
4.2 Market: Application Analysis, 2020 & 2028 (USD Million)
4.2.1 Therapeutic Injections
4.2.1.1 Market Estimates And Forecasts, 2014 - 2028 (USD Million)
4.2.2 Fluid Balance Injections
4.2.2.1 Market Estimates And Forecasts, 2014 - 2028 (USD Million)
4.2.3 Nutritious Injections
4.2.3.1 Market Estimates And Forecasts, 2014 - 2028 (USD Million)
CHAPTER 5 INDIA LARGE VOLUME PARENTERAL MARKET: VOLUME ESTIMATES & TREND ANALYSIS
5.1 Segment Dashboard
5.2 Market: Application Analysis, 2020 & 2028 (USD Million)
5.2.1 100 ML
5.2.1.1 Market estimates and forecasts, 2014 - 2028 (USD Million)
5.2.2 250 ML
5.2.2.1 Market estimates and forecasts, 2014 - 2028 (USD Million)
5.2.3 500 ML
5.2.3.1 Market estimates and forecasts, 2014 - 2028 (USD Million)
5.2.4 1000 ML
5.2.4.1 Market estimates and forecasts, 2014 - 2028 (USD Million)
5.2.5 2000 ML
5.2.5.1 Market estimates and forecasts, 2014 - 2028 (USD Million)
CHAPTER 6 INDIA LARGE VOLUME PARENTERAL MARKET: END-USE ESTIMATES & TREND ANALYSIS
6.1 Segment Dashboard
6.2 Market: End-use Analysis, 2020 & 2028 (USD Million)
6.2.1 Hospitals & other healthcare facilities
6.2.1.1 Market estimates and forecasts, 2014 - 2028 (USD Million)
6.2.2 Home care
6.2.2.1 Market estimates and forecasts, 2014 - 2028 (USD Million)
CHAPTER 7 COMPETITIVE LANDSCAPE
7.1 Strategy Framework
7.2 LVP Manufacturers in India
7.3 India LVP Market: Market Position Analysis (Based on Application, Product Benchmarking, Regional Presence, and Recent Updates)
7.3.1 Marketing Of Lvp To Healthcare Providers And Distribution Channels
7.4 Company Profiles
7.4.1 B. BRAUN MELSUNGEN AG
7.4.1.1 Company overview
7.4.1.2 Financial performance
7.4.1.3 Product benchmarking
7.4.1.4 Strategic initiatives
7.4.2 FRESENIUS KABI AG
7.4.2.1 Company overview
7.4.2.2 Financial performance
7.4.2.3 Product benchmarking
7.4.2.4 Strategic initiatives
7.4.3 BAXTER
7.4.3.1 Company overview
7.4.3.2 Financial performance
7.4.3.3 Product benchmarking
7.4.3.4 Strategic initiatives
7.4.4 OTSUKA PHARMACEUTICALS CO. LTD
7.4.4.1 Company overview
7.4.4.2 Financial performance
7.4.4.3 Product benchmarking
7.4.4.4 Strategic initiatives
7.4.5 SICHUAN KELUN
7.4.5.1 Company overview
7.4.5.2 Financial performance
7.4.5.3 Product benchmarking
7.4.6 ALBERT DAVID LTD.
7.4.6.1 Company overview
7.4.6.2 Financial performance
7.4.6.3 Product benchmarking
7.4.7 BML PARENTERAL DRUGS
7.4.7.1 Company overview
7.4.7.2 Financial performance
7.4.7.3 Product benchmarking
LIST OF TABLES
Table 1 List of secondary data sources
Table 2 India LVP market, by application, 2014 - 2028 (USD Million)
Table 3 India LVP market, by volume, 2014 - 2028 (USD Million)
Table 4 India LVP market, by end use, 2014 - 2028 (USD Million)
Table 5 LVP manufacturers in India
Table 1 List of secondary data sources
Table 2 India LVP market, by application, 2014 - 2028 (USD Million)
Table 3 India LVP market, by volume, 2014 - 2028 (USD Million)
Table 4 India LVP market, by end use, 2014 - 2028 (USD Million)
Table 5 LVP manufacturers in India
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 India Large Volume Parenteral market summary, 2020 (USD Million)
Fig. 5 India Large Volume Parenteral market trends & outlook
Fig. 6 India Large Volume Parenteral Market segmentation
Fig. 7 Market driver analysis (Current & future impact)
Fig. 8 Market restraint analysis (Current & future impact)
Fig. 9 Penetration & growth prospect mapping
Fig. 10 Procedure for drug application in India
Fig. 11 India Large Volume Parenteral market, application outlook key takeaways (USD Million)
Fig. 12 India Large Volume Parenteral market: Application movement analysis 2020 & 2028 (USD Million)
Fig. 13 Therapeutic injections market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 14 Fluid balance injections market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 15 Nutritious injections market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 16 India Large Volume Parenteral market, volume outlook key takeaways (USD Million)
Fig. 17 India Large Volume Parenteral market: Volume movement analysis 2020 & 2028 (USD Million)
Fig. 18 100 ml large volume parenteral market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 19 250 ml large volume parenteral market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 20 500 ml large volume parenteral market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 21 1,000 ml large volume parenteral market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 22 2,000 ml large volume parenteral market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 23 India Large Volume Parenteral market, end-use outlook key takeaways (USD Million)
Fig. 24 India Large Volume Parenteral market: End-use movement analysis 2020 & 2028 (USD Million)
Fig. 25 Hospital and other healthcare facilities market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 26 Homecare market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 27 Strategy Framework
Fig. 28 India LVP competitive landscape: Market position analysis (based on application, product benchmarking, and regional presence (2020)
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 India Large Volume Parenteral market summary, 2020 (USD Million)
Fig. 5 India Large Volume Parenteral market trends & outlook
Fig. 6 India Large Volume Parenteral Market segmentation
Fig. 7 Market driver analysis (Current & future impact)
Fig. 8 Market restraint analysis (Current & future impact)
Fig. 9 Penetration & growth prospect mapping
Fig. 10 Procedure for drug application in India
Fig. 11 India Large Volume Parenteral market, application outlook key takeaways (USD Million)
Fig. 12 India Large Volume Parenteral market: Application movement analysis 2020 & 2028 (USD Million)
Fig. 13 Therapeutic injections market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 14 Fluid balance injections market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 15 Nutritious injections market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 16 India Large Volume Parenteral market, volume outlook key takeaways (USD Million)
Fig. 17 India Large Volume Parenteral market: Volume movement analysis 2020 & 2028 (USD Million)
Fig. 18 100 ml large volume parenteral market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 19 250 ml large volume parenteral market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 20 500 ml large volume parenteral market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 21 1,000 ml large volume parenteral market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 22 2,000 ml large volume parenteral market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 23 India Large Volume Parenteral market, end-use outlook key takeaways (USD Million)
Fig. 24 India Large Volume Parenteral market: End-use movement analysis 2020 & 2028 (USD Million)
Fig. 25 Hospital and other healthcare facilities market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 26 Homecare market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 27 Strategy Framework
Fig. 28 India LVP competitive landscape: Market position analysis (based on application, product benchmarking, and regional presence (2020)
